Clinical Trial Update: Efficacy of BIO-K+ CL1285® Prophylaxis in the Prevention of Traveler's Diarrhea in Adults [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating BIO-K+ CL1285 Prophylaxis for preventing traveler's diarrhea in adults has completed; results are not detailed in the excerpt.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traveler Diarrhea

Drugs mentioned

• BIO-K+ CL1285 Prophylaxis

Snippet

Sponsor: Bio-K Plus International Inc. | Conditions: Diarrhea | Phase 3 | Status: COMPLETED